Use of FDG PET for Staging and Re-Staging of Head and Neck Squamous Cell Carcinoma
Cancers · 27.09.2025 · 17 (19) · 3140
DOI: 10.3390/cancers17193140 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 27.09.2025. Verfasst von Charles Marcus. Beteiligte Einrichtung: Division of Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Head and neck cancers account for approximately 3.0% of all new cancer diagnoses. 18F-FDG PET/CT plays an important role in the initial staging of these cancers, especially in the detection of nodal and distant metastatic disease, outperforming conventional imaging techniques. It helps identify occult primary tumors and synchronous second primary malignancies. PET/CT findings can lead to treatment plan alterations both in surgical and primary or adjuvant chemoradiation plans. High negative predictive value at treatment response assessment provides valuable prognostic implications. PET/CT can predict outcomes at baseline and during or after treatment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
- Division of Nuclear Medicine, Department of Radiology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Förderung
- NCI NIH HHS
Zitieren
APA
Marcus, C. (2025). Use of FDG PET for Staging and Re-Staging of Head and Neck Squamous Cell Carcinoma. Cancers, 17(19), 3140. https://doi.org/10.3390/cancers17193140
Vancouver
Marcus C. Use of FDG PET for Staging and Re-Staging of Head and Neck Squamous Cell Carcinoma. Cancers. 2025;17(19):3140. doi:10.3390/cancers17193140
BibTeX
@article{Marcus2025,
author = {Marcus, Charles},
title = {Use of FDG PET for Staging and Re-Staging of Head and Neck Squamous Cell Carcinoma},
journal = {Cancers},
year = {2025},
volume = {17},
number = {19},
pages = {3140},
doi = {10.3390/cancers17193140}
}
EUVIMED